Product Information
TOPIRAMATE 100 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.0567 per EA under NDC 29300011705. Its NADAC has been published 547 times since Apr 13, 2016.
FDA first approved this application on Mar 27, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Unichem Pharmaceuticals (USA) Inc.NDC
29300011705
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA090162FDA Approved
3/27/2009
TE Code
AB
On Market Since
7/1/2013
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE 100 MG TABLET has been published 547 times since Apr 13, 2016, and over the history we have for it it has declined 31.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0567 per EA |
|---|---|
| All-time high | $0.0823 (Nov 13, 2019) |
| All-time low | $0.0486 (Nov 20, 2024) |
| 52-week high | $0.0628 |
| 52-week low | $0.0550 |
| Median price | $0.0663 |
| Average price | $0.0675 |
| Largest weekly change | +33.1% (Aug 21, 2024) |
| Weeks tracked | 547 |
| Tracking since | Apr 13, 2016 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Unichem Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
topiramate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TOPIRAMATE 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 100 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.0567 per EA (NDC 29300011705), effective Sep 30, 2026.
How has the price of TOPIRAMATE 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE 100 MG TABLET has declined 31.0%. It has been tracked across 547 weekly CMS publications since Apr 13, 2016.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE 100 MG TABLET?
Since Apr 13, 2016, the NADAC for TOPIRAMATE 100 MG TABLET has ranged from a low of $0.0486 (Nov 20, 2024) to a high of $0.0823 (Nov 13, 2019), with a median of $0.0663 per EA.
Are there cheaper alternatives to TOPIRAMATE 100 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TOPIRAMATE 100 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TOPIRAMATE 100 MG TABLET?
TOPIRAMATE 100 MG TABLET (NDC 29300011705) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.